CliffBio
small molecule

NICORETTE

NICOTINE POLACRILEX

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameNICORETTE
Active ingredientNICOTINE POLACRILEX
StrengthEQ 4MG BASE
Dosage formTROCHE/LOZENGE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2002
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.